Release Date: 01/05/19 08:03 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 273.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%